肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

盘点：2018年度血液系统疾病相关新指南汇总(一)

2018-08-15 shaosai MedSci原创

血液系统新指南
关注

【盘点】2018年度血液系统疾病相关新指南汇总(一)

NCCN临床实践指南：急性髓性白血病（2018.V1）

指南名称：NCCN临床实践指南：急性髓性白血病（2018.V1）

英文标题：NCCN Clinical Practice Guidelines in Oncology：Acute Myeloid Leukemia（Version 1.2018）

发布机构：美国国家综合癌症网络(NCCN，National Comprehensive Cancer Network)

发布日期：2018-2-7

简要介绍：

2018年2月，美国国家综合癌症网络(NCCN)发布了急性髓性白血病指南2018年第1版，指南主要内容包括：

指南更新摘要

急性白血病和诊断研究评估(AML-1)

APL，诱导治疗(AML-2)

APL，诱导治疗和巩固治疗(AML-3)

APL，巩固后治疗(AML-6)

APL，复发治疗(AML-7)

AML，标准剂量阿糖胞苷诱导缓解后治疗（年龄＜60y）(AML-8)

AML，大剂量阿糖胞苷诱导缓解后治疗（年龄＜60y）(AML-9)

AML，缓解后治疗（年龄＜60y）(AML-10)

AML，诱导治疗（年龄＞60y）(AML-11)

AML，标准剂量阿糖胞苷诱导后治疗（年龄≥60y）(AML-12)

AML，缓解后治疗（年龄≥60y） (AML-13)

AML，监测(AML-14)

AML，复发/难治性疾病的治疗(AML-14)

基于验证细胞遗传学和分子异常风险状态(AML-A)

CNS淋巴瘤的评估和治疗(AML-B)

支持性治疗(AML-C)

急性髓系白血病反应标准(AML-D)

治疗期间监测(AML-E)

复发/难治性疾病的治疗(AML-F)


NCCN临床实践指南：急性髓性白血病（2018.V2）

指南名称：NCCN临床实践指南：急性髓性白血病（2018.V2）

英文标题：NCCN Clinical Practice Guidelines in Oncology：Acute Myeloid Leukemia（Version 2.2018）

发布机构：美国国家综合癌症网络(NCCN，National Comprehensive Cancer Network)

发布日期：2018-8-1

简要介绍：2018年8月，美国国家综合癌症网络(NCCN)发布了急性髓性白血病指南2018年第2版，指南主要内容包括：

指南更新摘要

急性白血病和诊断研究评估(AML-1)

APL，诱导治疗(AML-2)

APL，诱导治疗和巩固治疗(AML-3)

APL，巩固后治疗(AML-6)

APL，复发治疗(AML-7)

AML，标准剂量阿糖胞苷诱导缓解后治疗（年龄＜60y）(AML-8)

AML，大剂量阿糖胞苷诱导缓解后治疗（年龄＜60y）(AML-9)

AML，缓解后治疗（年龄＜60y）(AML-10)

AML，诱导治疗（年龄＞60y）(AML-11)

AML，标准剂量阿糖胞苷诱导后治疗（年龄≥60y）(AML-12)

AML，缓解后治疗（年龄≥60y） (AML-13)

AML，监测(AML-14)

AML，复发/难治性疾病的治疗(AML-14)

基于验证细胞遗传学和分子异常风险状态(AML-A)

CNS淋巴瘤的评估和治疗(AML-B)

支持性治疗(AML-C)

急性髓系白血病反应标准(AML-D)

治疗期间监测(AML-E)

复发/难治性疾病的治疗(AML-F)


NCCN临床实践指南：急性髓性白血病（2017.V3）

指南名称：NCCN临床实践指南：急性髓性白血病（2017.V3）

英文标题：NCCN Clinical Practice Guidelines in Oncology：Acute Myeloid Leukemia（Version 3.2017）

发布机构：美国国家综合癌症网络(NCCN，National Comprehensive Cancer Network)

发布日期：2017-6-6

简要介绍：

2017年6月，美国国家综合癌症网络(NCCN)发布了急性髓性白血病指南2017年第3版，指南主要内容包括： 指南更新摘要 急性白血病和诊断研究评估(AML-1) APL，诱导治疗(AML-2) APL，巩固后治疗(AML-5) APL，复发治疗(AML-7) AML，治疗反应（年龄＜60y）(AML-7) AML，标准剂量阿糖胞苷诱导缓解后治疗（年龄＜60y）(AML-8) AML，大剂量阿糖胞苷诱导缓解后治疗（年龄＜60y）(AML-9) AML，缓解后治疗（年龄＜60y）(AML-10) AML，诱导治疗（年龄＞60y）(AML-11) AML，标准剂量阿糖胞苷诱导后治疗（年龄≥60y）(AML-12) AML，缓解后治疗（年龄≥60y） (AML-13) AML，监测(AML-14) AML，复发/难治性疾病的治疗(AML-14) 基于验证细胞遗传学和分子异常风险状态(AML-A) CNS淋巴瘤的评估和治疗(AML-B) 支持性治疗(AML-C) 急性髓系白血病反应标准(AML-D) 治疗期间监测(AML-E) 复发/难治性疾病的治疗(AML-F)


NCCN临床实践指南：慢性髓性白血病（2019.V1-4）

指南名称：NCCN临床实践指南：慢性髓性白血病（2019.V1）

英文标题：NCCN Clinical Practice Guidelines in Oncology：Chronic Myeloid Leukemia (Version 1.2019)

发布机构：美国国家综合癌症网络(NCCN，National Comprehensive Cancer Network)

发布日期：2018-8-1

简要介绍：2018年8月，美国国家综合癌症网络(NCCN)发布了慢性髓性白血病指南2019年第1版，指南主要内容涉及：

更新摘要

检查

慢性期CML：初始治疗治疗

治疗响应时间表，临床注意事项以及治疗方案

进展期CML：初始治疗

基于BCR-ABL1基因突变的治疗方案

造血干细胞移植

风险评估表

加速阶段定义

爆发阶段定义

TKI治疗反映监测反映和突变分析

IBD%E8%AF%8A%E6%B2%BB%E8%BF%87%E7%A8%8B%E4%B8%AD%E7%9A%84%E8%AF%84%E4%BC%B0-Part%202" target="_blank">血液，遗传学和分析反映和复发的标准

TKI治疗停药标准

各种治疗药物毒性的管理


2018 ESMO临床实践指南：癌症患者贫血和铁缺乏的管理

指南名称：2018 ESMO临床实践指南：癌症患者贫血和铁缺乏的管理

英文标题：Management of anaemia and iron deficiency in patients with cancer： ESMO Clinical Practice Guidelines.

发布机构：欧洲肿瘤内科学会(ESMO，European Society for Medical Oncology)

发布日期：2018-2-20

简要介绍：

2018年2月，欧洲肿瘤内科学会(ESMO)发布了癌症患者贫血和铁缺乏的管理指南。贫血和缺铁是实体肿瘤和IBD%E8%AF%8A%E6%B2%BB%E8%BF%87%E7%A8%8B%E4%B8%AD%E7%9A%84%E8%AF%84%E4%BC%B0-Part%202" target="_blank">血液恶性肿瘤，尤其是接受化疗药物治疗患者最常见的并发症，本文主要针对贫血的评估以及补铁治疗方法提出指导建议，主要目的是优化癌症患者贫血和铁缺乏的管理。


重视癌症患者贫血，早期筛查与治疗铁缺乏——欧洲《成年癌症患者铁缺乏的管理意见书》解读

指南名称：重视癌症患者贫血，早期筛查与治疗铁缺乏——欧洲《成年癌症患者铁缺乏的管理意见书》解读

发布日期：2018-1-30

简要介绍：

贫血是肿瘤患者常见的并发症，而铁缺乏是其最常见的病因之一。本文对欧洲肿瘤及血液学专家组2017 年发布的《成年癌症患者铁缺乏的管理意见书》进行了解读，并与国内外肿瘤相关贫血指南、既往文献进行对比与总结，重点强调：应在癌症患者中早期定期评估和监测铁参数，早期识别和治疗贫血，以促红细胞生成类药物和铁剂补充作为绝对性铁缺乏和功能性缺铁的治疗基石，减少不必要的输血。


NCCN临床实践指南：癌症和化疗诱导的贫血

指南名称：NCCN临床实践指南：癌症和化疗诱导的贫血（2018.V1）

英文标题：NCCN clinical practice guidelines in Oncology：Cancer- and Chemotherapy-Induced Anemia（2018.V1）

发布机构：美国国家综合癌症网络(NCCN，National Comprehensive Cancer Network)

发布日期：2017-6-23

简要介绍：2017年6月，美国国家综合癌症网络(NCCN)发布了癌症和化疗诱导的贫血指南2018年第1版，指南主要内容涉及：

指南更新摘要

贫血评估

急诊首次输血适应症和风险评估

ESA使用与红细胞输注的风险和目标

ESA应用特殊类别考虑

缺铁评估

红细胞输注的适应症

红细胞生成治疗

肠外铁剂

拒绝输血的癌症和化疗诱导的贫血患者的管理

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2007240, encodeId=7587200e2408a, content=<a href='/topic/show?id=dadd8933078' target=_blank style='color:#2F92EE;'>#血液系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89330, encryptionId=dadd8933078, topicName=血液系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Sep 01 08:29:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923364, encodeId=6aa219233645e, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Oct 03 11:29:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028526, encodeId=edf82028526c5, content=<a href='/topic/show?id=966889328d8' target=_blank style='color:#2F92EE;'>#血液系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89328, encryptionId=966889328d8, topicName=血液系统)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Jun 23 07:29:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338891, encodeId=fd1e338891c7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Thu Aug 16 08:07:52 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338886, encodeId=38b433888672, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Thu Aug 16 07:38:05 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338878, encodeId=85a63388e84e, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 16 07:09:42 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338870, encodeId=a2a23388e078, content=优质资源，共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Thu Aug 16 06:26:41 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338855, encodeId=bf1f33885552, content=学习了感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Thu Aug 16 00:13:29 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338853, encodeId=e1d83388534d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/05/2be42de705dd506439382c6df2ef7ff1.jpg, createdBy=f3e12414585, createdName=三不猴, createdTime=Wed Aug 15 23:57:07 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
    2018-09-01 小小小向日葵

    #血液系统疾病#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2007240, encodeId=7587200e2408a, content=<a href='/topic/show?id=dadd8933078' target=_blank style='color:#2F92EE;'>#血液系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89330, encryptionId=dadd8933078, topicName=血液系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Sep 01 08:29:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923364, encodeId=6aa219233645e, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Oct 03 11:29:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028526, encodeId=edf82028526c5, content=<a href='/topic/show?id=966889328d8' target=_blank style='color:#2F92EE;'>#血液系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89328, encryptionId=966889328d8, topicName=血液系统)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Jun 23 07:29:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338891, encodeId=fd1e338891c7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Thu Aug 16 08:07:52 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338886, encodeId=38b433888672, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Thu Aug 16 07:38:05 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338878, encodeId=85a63388e84e, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 16 07:09:42 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338870, encodeId=a2a23388e078, content=优质资源，共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Thu Aug 16 06:26:41 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338855, encodeId=bf1f33885552, content=学习了感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Thu Aug 16 00:13:29 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338853, encodeId=e1d83388534d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/05/2be42de705dd506439382c6df2ef7ff1.jpg, createdBy=f3e12414585, createdName=三不猴, createdTime=Wed Aug 15 23:57:07 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
    2018-10-03 12498768m13(暂无昵称)

    #新指南#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2007240, encodeId=7587200e2408a, content=<a href='/topic/show?id=dadd8933078' target=_blank style='color:#2F92EE;'>#血液系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89330, encryptionId=dadd8933078, topicName=血液系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Sep 01 08:29:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923364, encodeId=6aa219233645e, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Oct 03 11:29:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028526, encodeId=edf82028526c5, content=<a href='/topic/show?id=966889328d8' target=_blank style='color:#2F92EE;'>#血液系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89328, encryptionId=966889328d8, topicName=血液系统)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Jun 23 07:29:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338891, encodeId=fd1e338891c7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Thu Aug 16 08:07:52 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338886, encodeId=38b433888672, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Thu Aug 16 07:38:05 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338878, encodeId=85a63388e84e, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 16 07:09:42 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338870, encodeId=a2a23388e078, content=优质资源，共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Thu Aug 16 06:26:41 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338855, encodeId=bf1f33885552, content=学习了感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Thu Aug 16 00:13:29 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338853, encodeId=e1d83388534d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/05/2be42de705dd506439382c6df2ef7ff1.jpg, createdBy=f3e12414585, createdName=三不猴, createdTime=Wed Aug 15 23:57:07 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
    2019-06-23 旅苦化文_208

    #血液系统#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2007240, encodeId=7587200e2408a, content=<a href='/topic/show?id=dadd8933078' target=_blank style='color:#2F92EE;'>#血液系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89330, encryptionId=dadd8933078, topicName=血液系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Sep 01 08:29:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923364, encodeId=6aa219233645e, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Oct 03 11:29:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028526, encodeId=edf82028526c5, content=<a href='/topic/show?id=966889328d8' target=_blank style='color:#2F92EE;'>#血液系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89328, encryptionId=966889328d8, topicName=血液系统)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Jun 23 07:29:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338891, encodeId=fd1e338891c7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Thu Aug 16 08:07:52 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338886, encodeId=38b433888672, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Thu Aug 16 07:38:05 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338878, encodeId=85a63388e84e, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 16 07:09:42 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338870, encodeId=a2a23388e078, content=优质资源，共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Thu Aug 16 06:26:41 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338855, encodeId=bf1f33885552, content=学习了感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Thu Aug 16 00:13:29 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338853, encodeId=e1d83388534d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/05/2be42de705dd506439382c6df2ef7ff1.jpg, createdBy=f3e12414585, createdName=三不猴, createdTime=Wed Aug 15 23:57:07 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
    2018-08-16 一天没事干

    很好的学习机会

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2007240, encodeId=7587200e2408a, content=<a href='/topic/show?id=dadd8933078' target=_blank style='color:#2F92EE;'>#血液系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89330, encryptionId=dadd8933078, topicName=血液系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Sep 01 08:29:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923364, encodeId=6aa219233645e, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Oct 03 11:29:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028526, encodeId=edf82028526c5, content=<a href='/topic/show?id=966889328d8' target=_blank style='color:#2F92EE;'>#血液系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89328, encryptionId=966889328d8, topicName=血液系统)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Jun 23 07:29:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338891, encodeId=fd1e338891c7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Thu Aug 16 08:07:52 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338886, encodeId=38b433888672, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Thu Aug 16 07:38:05 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338878, encodeId=85a63388e84e, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 16 07:09:42 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338870, encodeId=a2a23388e078, content=优质资源，共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Thu Aug 16 06:26:41 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338855, encodeId=bf1f33885552, content=学习了感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Thu Aug 16 00:13:29 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338853, encodeId=e1d83388534d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/05/2be42de705dd506439382c6df2ef7ff1.jpg, createdBy=f3e12414585, createdName=三不猴, createdTime=Wed Aug 15 23:57:07 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
    2018-08-16 183****7028

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2007240, encodeId=7587200e2408a, content=<a href='/topic/show?id=dadd8933078' target=_blank style='color:#2F92EE;'>#血液系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89330, encryptionId=dadd8933078, topicName=血液系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Sep 01 08:29:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923364, encodeId=6aa219233645e, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Oct 03 11:29:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028526, encodeId=edf82028526c5, content=<a href='/topic/show?id=966889328d8' target=_blank style='color:#2F92EE;'>#血液系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89328, encryptionId=966889328d8, topicName=血液系统)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Jun 23 07:29:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338891, encodeId=fd1e338891c7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Thu Aug 16 08:07:52 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338886, encodeId=38b433888672, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Thu Aug 16 07:38:05 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338878, encodeId=85a63388e84e, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 16 07:09:42 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338870, encodeId=a2a23388e078, content=优质资源，共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Thu Aug 16 06:26:41 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338855, encodeId=bf1f33885552, content=学习了感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Thu Aug 16 00:13:29 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338853, encodeId=e1d83388534d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/05/2be42de705dd506439382c6df2ef7ff1.jpg, createdBy=f3e12414585, createdName=三不猴, createdTime=Wed Aug 15 23:57:07 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
    2018-08-16 1209e435m98(暂无昵称)

    学习了，谢谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2007240, encodeId=7587200e2408a, content=<a href='/topic/show?id=dadd8933078' target=_blank style='color:#2F92EE;'>#血液系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89330, encryptionId=dadd8933078, topicName=血液系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Sep 01 08:29:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923364, encodeId=6aa219233645e, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Oct 03 11:29:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028526, encodeId=edf82028526c5, content=<a href='/topic/show?id=966889328d8' target=_blank style='color:#2F92EE;'>#血液系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89328, encryptionId=966889328d8, topicName=血液系统)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Jun 23 07:29:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338891, encodeId=fd1e338891c7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Thu Aug 16 08:07:52 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338886, encodeId=38b433888672, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Thu Aug 16 07:38:05 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338878, encodeId=85a63388e84e, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 16 07:09:42 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338870, encodeId=a2a23388e078, content=优质资源，共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Thu Aug 16 06:26:41 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338855, encodeId=bf1f33885552, content=学习了感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Thu Aug 16 00:13:29 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338853, encodeId=e1d83388534d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/05/2be42de705dd506439382c6df2ef7ff1.jpg, createdBy=f3e12414585, createdName=三不猴, createdTime=Wed Aug 15 23:57:07 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
    2018-08-16 九九消寒

    优质资源，共同学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2007240, encodeId=7587200e2408a, content=<a href='/topic/show?id=dadd8933078' target=_blank style='color:#2F92EE;'>#血液系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89330, encryptionId=dadd8933078, topicName=血液系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Sep 01 08:29:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923364, encodeId=6aa219233645e, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Oct 03 11:29:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028526, encodeId=edf82028526c5, content=<a href='/topic/show?id=966889328d8' target=_blank style='color:#2F92EE;'>#血液系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89328, encryptionId=966889328d8, topicName=血液系统)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Jun 23 07:29:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338891, encodeId=fd1e338891c7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Thu Aug 16 08:07:52 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338886, encodeId=38b433888672, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Thu Aug 16 07:38:05 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338878, encodeId=85a63388e84e, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 16 07:09:42 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338870, encodeId=a2a23388e078, content=优质资源，共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Thu Aug 16 06:26:41 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338855, encodeId=bf1f33885552, content=学习了感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Thu Aug 16 00:13:29 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338853, encodeId=e1d83388534d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/05/2be42de705dd506439382c6df2ef7ff1.jpg, createdBy=f3e12414585, createdName=三不猴, createdTime=Wed Aug 15 23:57:07 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
    2018-08-16 lofter

    学习了感谢分享

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2007240, encodeId=7587200e2408a, content=<a href='/topic/show?id=dadd8933078' target=_blank style='color:#2F92EE;'>#血液系统疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89330, encryptionId=dadd8933078, topicName=血液系统疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Sat Sep 01 08:29:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923364, encodeId=6aa219233645e, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Wed Oct 03 11:29:00 CST 2018, time=2018-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028526, encodeId=edf82028526c5, content=<a href='/topic/show?id=966889328d8' target=_blank style='color:#2F92EE;'>#血液系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89328, encryptionId=966889328d8, topicName=血液系统)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Jun 23 07:29:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338891, encodeId=fd1e338891c7, content=很好的学习机会, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Thu Aug 16 08:07:52 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338886, encodeId=38b433888672, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Thu Aug 16 07:38:05 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338878, encodeId=85a63388e84e, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Aug 16 07:09:42 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338870, encodeId=a2a23388e078, content=优质资源，共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Thu Aug 16 06:26:41 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338855, encodeId=bf1f33885552, content=学习了感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/C20CB8E4EBB36F5B821651C710BCB491/100, createdBy=18de1715848, createdName=lofter, createdTime=Thu Aug 16 00:13:29 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338853, encodeId=e1d83388534d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/05/2be42de705dd506439382c6df2ef7ff1.jpg, createdBy=f3e12414585, createdName=三不猴, createdTime=Wed Aug 15 23:57:07 CST 2018, time=2018-08-15, status=1, ipAttribution=)]
    2018-08-15 三不猴

    谢谢分享

    0

相关资讯

ASCO 2016：已婚肿瘤患者生存几率明显高于未婚肿瘤患者

幸福的婚姻有助于增加收入,改善生活质量,消除人们的孤独感，并给予他们安全感和终身陪伴的感觉。但是,结婚对民众有促进健康的好处吗？一项新的研究表明，答案是肯定的! 结婚可以帮助民众抵抗癌症。研究结果发表在美国临床肿瘤学会年度会议(ASCO)上。 在两个研究中,研究人员发现,已婚夫妇活得更久的可能性是未婚人们的两倍。此外,由于已婚男女的稳定性生活，他们患性病的风险降低。此外,已婚民众抵抗疾病的能力更强

Nature：救命！科学家发现生长造血干细胞的新方法

麦克马斯特大学干细胞和癌症研究所（McMaster University's Stem Cell and Cancer Research Institute）研究人员在理解人类血液系统干细胞方面取得了重大进步，他们发现了一种关键蛋白质如何允许这些细胞更好的控制和再生。 这项研究最新发表于《Nature》期刊，阐明了一种被称为Musashi-2的蛋白质如何调节重要造血干细胞的功能和发育。

Lancet Oncol：来那度胺增加骨髓瘤血液系统第二原发瘤风险

在多发性骨髓瘤患者中，自从引入了大剂量马法兰治疗和自体干细胞移植术后，以及硼替佐米和免疫调节制剂如沙利度胺和来那度胺治疗之后，这些患者的生存期得到了明显的改善。但是，随着生存期的增加，预期存活时间也随之增加，从而引发了人们对于在上述患者群体中第二原发恶性肿瘤发生风险增高的思考。 在上述患者群体中，应用来那度胺治疗与第二原发恶性肿瘤的发生风险增高相关。在本文中，来自

Clin Microbiol Infect：血液系统恶性肿瘤患者：伏立康唑超治疗血药浓度是否安全？

无神经系统毒性症状的血液系统恶性肿瘤合并超治疗伏立康唑血药浓度患者之后发生中枢神经系统毒性几率如何？2017年6月，发表在《Clin Microbiol Infect.》的一项研究对此进行分析。